D. O'Toole - 30 May 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: CFO
Signature: /s/ Donna Shiroma
Issuer symbol: RCEL
Transactions as of: 30 May 2024
Transactions value $: $27,197
Form type: 4
Filing time: 03 Jun 2024, 16:27:02 UTC
Previous filing: 28 Feb 2024
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Purchase	$4.6K	+500	+2.67%	$9.20	19.2K	30 May 2024	Direct
transaction	RCEL	Common Stock	Purchase	$4.3K	+500	+2.6%	$8.60	19.7K	30 May 2024	Direct
transaction	RCEL	Common Stock	Award	$18.3K	+2.24K	+11.35%	$8.17	22K	31 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period).

Content

These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period).